LIST OF RECOMMENDATIONS
Recommendation 1
6.20 The
committee recommends that the Government should not proceed with further
co-payments.
Recommendation 2
6.21 The
committee recommends that the Government undertake a comprehensive review of
the impact of existing co-payments on individuals' access to health services
and health outcomes. The review should pay particular attention to the impact
on the most vulnerable groups in the community.
Recommendation 3
6.22 The
committee recommends that the Government review the impact and effectiveness of
existing safety nets to ensure that current safeguards provide adequate
protection to the most vulnerable in the community.
Recommendation 4
6.26 The
committee recommends that the Government review the Pharmaceutical Benefits
Scheme to identify areas where efficiencies can be gained, with particular
reference to the following areas:
- current procurement
and pricing structures, with particular reference to examining benchmarking as
a mechanism to explore the extent to which savings could be achieved;
- effective monitoring
and review of GP prescribing practices to ensure dispensed medications are cost
effective and evidence based; and
- evaluation of the
prevalence of patient non-adherence to prescribed medication, with particular
reference to identifying reasons for non-adherence.
Recommendation 5
6.32 The
committee recommends that the Government review existing models for funding and
delivery of primary healthcare with a view to identifying opportunities for
improved service delivery and health outcomes.
Navigation: Previous Page | Contents | Next Page